Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Junghee Jenny Shin"'
Autor:
Serhan Ünlü, Junghee Jenny Shin, Jennefer Par-Young, Michael Simonov, Joseph Vinetz, Daniel P. Petrylak, Insoo Kang, Joseph W. Kim
Publikováno v:
Cancer Investigation. 41:77-83
TMPRSS2 is utilized by SARS-CoV-2 for cellular entry. Androgen-Androgen receptor directed therapy (A/ARDT) downregulates expression of TMPRSS2. We hypothesized A/ARDT might protect prostate cancer (PCa) patients from poor COVID-19 outcome. A retrospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c124e8f3f31df7d6372acea2425403b3
https://doi.org/10.1080/07357907.2022.2139839
https://doi.org/10.1080/07357907.2022.2139839
Autor:
Junghee Jenny Shin, Jennefer Par-Young, Serhan Unlu, Andrew McNamara, Hong-Jai Park, Min Sun Shin, Renelle J. Gee, Hester Doyle, Yuliya Afinogenova, Elena Zidan, Jason Kwah, Armand Russo, Mark Mamula, Florence Ida Hsu, Jason Catanzaro, Michael Racke, Richard Bucala, Craig Wilen, Insoo Kang
Publikováno v:
Journal of clinical immunology. 42(6)
Immune responses to coronavirus disease 2019 (COVID-19) mRNA vaccines in primary antibody deficiencies (PADs) are largely unknown. We investigated antibody and CD4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7462055df3ea23294e7147a0af6ea3a7
https://pubmed.ncbi.nlm.nih.gov/35713752
https://pubmed.ncbi.nlm.nih.gov/35713752
Autor:
Serhan Unlu, Junghee Jenny Shin, Jennefer Par-Young, Joseph Vinetz, Daniel P. Petrylak, Insoo Kang, Joseph W. Kim
Publikováno v:
Journal of Clinical Oncology. 40:161-161
161 Background: TMPRSS2 is one of the two key enzymes that SARS-CoV-2 requires for its entry to the cell. TMPRSS2 is regulated by androgen receptor. It is well described Androgen Receptor Directed Therapy (ARDT) downregulates the expression of TMPRSS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd7dafeccdc32e82edd36cd49a1bb1be
https://doi.org/10.1200/jco.2022.40.6_suppl.161
https://doi.org/10.1200/jco.2022.40.6_suppl.161